In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma
Marc‐Eric Halatsch(Kantonsspital Winterthur), Georg Karpel‐Massler(Universität Ulm)
Cited by 24
Related Papers
TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2015|65
Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2016|56